Evaluation of dual p16/Ki‐67 immunostaining on anal cytology specimens

Author:

Smithgall Marie C.1ORCID,Towne William S.1,Gonzalez Abel A.1,Cimic Adela1

Affiliation:

1. Department of Pathology and Cell Biology Columbia University Irving Medical Center New York New York USA

Abstract

AbstractIntroductionDual immunostaining for p16/Ki67 is FDA‐approved for use on liquid‐based cervical cytology specimens; however, the utility of dual staining in anal cytology especially for ASCUS risk stratification is not well established.MethodsWe investigated dual staining performance on anal cytology specimens and correlated with subsequent cytologic interpretation, high‐risk HPV status, and anal biopsy results. Dual staining for p16/Ki‐67 was performed on all liquid‐based anal cytology specimens from December 2021 to June 2022 (n = 43).ResultsThree patients had high grade squamous intraepithelial lesion (HSIL/AIN2‐3) on biopsy; dual staining was positive in all three cases. All HR‐HPV negative cases were negative for dual staining. Among the 12 ASCUS samples with subsequent anal biopsy results all also had HR‐HPV testing. Due to small sample size of cases with squamous intraepithelial lesion (SIL) diagnosed on biopsy, the sensitivity and positive predictive value was not calculated. However, the specificity and negative predictive value of p16/Ki‐67 dual staining for SIL of any grade on biopsy were 1 (95% CI: 0.66–1) and 0.9 (95% CI: 0.65–0.97) respectively, whereas the specificity and negative predictive value of HR‐HPV testing for SIL of any grade on biopsy were 0.44 (95% CI: 0.14–0.79) and 0.8 (95% CI: 0.41–0.96) respectively.ConclusionDual p16/Ki‐67 staining indicates transforming HPV infection and could help serve as an ancillary test for risk stratification for atypical anal cytology specimens. Among ASCUS samples, dual staining was specific for SIL of any grade with a high negative predictive value and therefore could be useful in clinical practices with limited availability for follow‐up care.

Funder

Irving Medical Center, Columbia University

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3